Equfina tablets 50mg

Equfina tablets 50mg (YJ code: 1169018F1020, standard: 50mg 1 tablet) are manufactured by Eisai. This medication, containing safinamide mesylate, is used to improve “wearing-off” phenomena in Parkinson’s disease patients receiving levodopa-containing products. It acts as a selective and reversible MAO-B inhibitor and also blocks voltage-dependent sodium channels and inhibits glutamate release.